HCM
IMGN

Highlander Capital Management’s Immunogen Inc IMGN Stock Holding History

Highlander Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,000
Closed -$15K – 657
2019
Q4 		$15K Buy
+3,000
New +$10.2K 0.01% 465

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Highlander Capital Management's IMGN Position: Q1 2020 in Review

Highlander Capital Management sold out of Immunogen Inc (IMGN) in Q1 2020, closing a stake of 3,000 shares — an estimated $15K sold.

Highlander Capital Management first reported a position in IMGN in Q4 2019 and held it in 1 quarter. The position peaked at $15K in Q4 2019. 185 funds tracked by Wall St. Rank hold IMGN as of Q1 2020.

  • Highlander Capital Management reported no remaining Immunogen Inc position as of Q1 2020 after selling out during the quarter.
  • Highlander Capital Management sold 3,000 Immunogen Inc shares in Q1 2020, an estimated $15K.
  • Highlander Capital Management first reported a position in Immunogen Inc in Q4 2019 and held it in 1 quarter.
  • Highlander Capital Management's Immunogen Inc position peaked at $15K in Q4 2019.
  • 185 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2020.

Based on Highlander Capital Management's 13F filing for Q1 2020, filed 27 May 2020.